Oric Pharmaceuticals, Inc.
Pharmaceutical company · South San Francisco, California, United States · Nasdaq: ORIC
Oric Pharmaceuticals, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its shares trade on Nasdaq under the ticker ORIC. It has reported private securities offerings to the US SEC, most recently $125 million sold in a notice filed in 2025.
Oric Pharmaceuticals at a glance
What does Oric Pharmaceuticals do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $125 million sold (2025).
Frequently asked questions about Oric Pharmaceuticals
Where is Oric Pharmaceuticals headquartered?
Oric Pharmaceuticals, Inc. is headquartered in South San Francisco, California, United States.
What does Oric Pharmaceuticals do?
Oric Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Oric Pharmaceuticals a public company?
Yes. Oric Pharmaceuticals, Inc. trades on Nasdaq under the ticker ORIC.
Similar companies
- CytomX Therapeutics, Inc.South San Francisco, California, United States
- Vistagen Therapeutics, Inc.South San Francisco, California, United States
- Portola Pharmaceuticals IncSouth San Francisco, California, United States
- IDEAYA Biosciences, Inc.South San Francisco, California, United States
- Spruce Biosciences, Inc.South San Francisco, California, United States
- Meissa Vaccines IncSouth San Francisco, California, United States
- GigaGen, Inc.South San Francisco, California, United States
- Alumis Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.